Navigation Links
ATS in Medical News

ATS Medical Announces First Use of the New ATS CryoMaze 10-S Probe

MINNEAPOLIS, July 20 /PRNewswire-FirstCall/ -- ATS Medical, Inc. (Nasdaq: ATSI ), manufacturer and marketer of state-of-the-art cardiac surgery products and services, today announced the first commercial use of the new ATS CryoMaze(TM) 10-S Surgical Cryoablation Probe for the treatment...

ATS Medical Announces FDA Clearance and First Implant of New ATS Simulus Semi-Rigid Annuloplasty Band

MINNEAPOLIS, July 6 /PRNewswire-FirstCall/ -- ATS Medical, Inc. (Nasdaq: ATSI ), manufacturer and marketer of state-of-the-art cardiac surgery products and services, today announced FDA clearance and the first implant of the ATS Simulus(R) Semi-Rigid Annuloplasty Band. The Simulus Semi-Rigid Ann...

Coalition for Pulmonary Fibrosis Announces Awards and Activities at ATS International Conference

CPF Recognized for Advancing Research and Patient Advocacy Efforts SAN DIEGO, May 18 /PRNewswire-USNewswire/ -- The Coalition for Pulmonary Fibrosis (CPF) today announced awards received at the American Thoracic Society's (ATS) International conference in San Diego, Calif. being held this wee...

ATS Medical Announces FDA Clearance of the ATS Simulus Adjustable Annuloplasty Band

Expands Heart Valve Repair Product Portfolio MINNEAPOLIS, May 12 /PRNewswire-FirstCall/ -- ATS Medical, Inc. (Nasdaq: ATSI ), manufacturer and marketer of state-of-the-art cardiac surgery products and services, today announced FDA clearance of the ATS Simulus(R) Adjustable Annuloplasty Band...

Pivotal Data on Bronchial Thermoplasty from the Asthma Intervention Research 2 (AIR2) Trial to be Presented at ATS 2009

New non-drug procedure for severe asthma featured in eight presentations at annual conference in San Diego SUNNYVALE, Calif., May 6 /PRNewswire/ -- Asthmatx released today the schedule of presentations featuring its novel Alair(R) Bronchial Thermoplasty System at ATS 2009, the Internation...

ATS Medical Announces Regulatory Approval of the ATS Open Pivot AP360 Mechanical Heart Valve in Japan

MINNEAPOLIS, April 16 /PRNewswire-FirstCall/ -- ATS Medical, Inc. (Nasdaq: ATSI ), manufacturer and marketer of state-of-the-art cardiac surgery products and services, today announced the Japanese Ministry of Health, Labor and Welfare has approved commercial distribution of the ATS Open Pivot(R)...

ATS Medical Announces Australian Regulatory Approval for ATS 3f Aortic Bioprosthesis

MINNEAPOLIS, Feb. 5 /PRNewswire-FirstCall/ -- ATS Medical, Inc. (Nasdaq: ATSI ), manufacturer and marketer of state-of-the-art cardiac surgery products and services, announced today that the Australian Therapeutic Goods Administration (TGA) has granted approval for commercialization of the A...

ATS Medical Announces First Commercial Implants of the ATS 3f Aortic Bioprosthesis in the United States

MINNEAPOLIS, Nov. 24 /PRNewswire-FirstCall/ -- ATS Medical, Inc. (Nasdaq: ATSI ), manufacturer and marketer of state-of-the-art cardiac surgery products and services, today announced that the first three commercial implants of the ATS 3f(R) Aortic Bioprosthesis were completed by Dr. Allan Stewar...

ATS Medical Announces FDA Approval of the ATS 3f Aortic Bioprosthesis

MINNEAPOLIS, Oct. 30 /PRNewswire-FirstCall/ -- ATS Medical, Inc. (Nasdaq: ATSI ), manufacturer and marketer of state-of-the-art cardiac surgery products and services, today announced it has received U.S. Food and Drug Administration (FDA) approval for the ATS 3f(R) Aortic Bioprosthesis. (Lo...

Clinical Trial Data for Perforomist(TM) Inhalation Solution to be Presented at ATS on May 20, 2008

- Data demonstrates safety and efficacy of first FDA-approved nebulized formoterol fumarate in patients with moderate to severe COPD - NAPA, Calif., May 16 /PRNewswire/ -- Dey, L.P. announced today that three clinical data presentations will be given at the International Conference of the ...

More>>

ATS in Medical Technology

ATS Medical Announces Initial Clinical Results of Stand-Alone Atrial Fibrillation Procedures Using ATS CryoMaze Product Line

Greater than 90% Success Rate at Six-Month Follow-up of 57 Patients MINNEAPOLIS, Feb. 22 /PRNewswire-FirstCall/ -- ATS Medical, Inc. (Nasdaq: ATSI ), manufacturer and marketer of state-of-the-art cardiac surgery products, today announced initial clinical results of stand-alone ablation proc...

PARI Pharma's Nebulized DSCG Shows Results Similar to Inhaled Steroids in Asthma Studies Presented at ATS

Positive Results Based on New DSCG Formulation & eFlow Technology Delivery MUNICH and MONTEREY, Calif., May 20 /PRNewswire/ -- This week, Swiss researchers presented positive data from an ongoing Phase II clinical study at the American Thoracic Society (ATS) International Conference that ...

Clinical Trial Data for Perforomist Inhalation Solution to be Presented at ATS on May 20, 2007

-- Data from Phase III pivotal trial demonstrate safety and efficacy of first FDA-approved nebulized formoterol fumarate for patients with moderate to severe COPD -- NAPA, Calif., May 16, 2007 /PRNewswire/ -- Dey, L.P. announced that two clinical data presentations will be given at the Internation...

Clinical Trial Data for Perforomist (Formoterol Fumarate) Inhalation Solution Presented at International ATS Conference

-- New product recently approved by FDA for long-term maintenance treatment of COPD bronchoconstriction; data demonstrate first nebulized formoterol fumarate provides improved lung function comparable to dry powder formoterol, enhanced patient quality of life, and positive safety profile -- NAPA, ...

Clinical Trial Data for Perforomist (Formoterol Fumarate) Inhalation Solution Presented at International ATS Conference

-- New product recently approved by FDA for long-term maintenance treatment of COPD bronchoconstriction; data demonstrate first nebulized formoterol fumarate provides improved lung function comparable to dry powder formoterol, enhanced patient quality of life, and positive safety profile -- NAPA...

Results of Two Phase 3 CAPACITY Studies of Pirfenidone in IPF Presented at American Thoracic Society (ATS)

...DDITIONAL EXPLORATORY EFFICACY RESULTS REPORTED AT ats The ats presentation highlighted new efficacy data from CA... a descriptive fashion. Dr. Noble reported at the ats meeting data on the low-dose pirfenidone group for...

Pivotal Data Show Bronchial Thermoplasty Can Improve Quality of Life and Reduce Asthma Attacks and Emergency Room Visits for Adults with Severe Asthma

... Non-drug Procedure for Asthma Highlighted at ats 2009 SUNNYVALE, Calif., May 18 /PRNewswire/ -- Results of the Asthma I...l Thermoplasty System, developed by Asthmatx, Inc., were announced today at ats 2009, the International Conference of the American Thoracic Society, in San...

Treprostinil Data Presented at American Thoracic Society Conference Demonstrates Significant Clinical Progress in All Four Routes of Administration

...ted at the American Thoracic Society (ATS) meeting in Toronto, Ontario. The ats presentations involved treprostinil delivered by inhaled, oral, intravenous...rapeutics will host an investor Q&A session following the conclusion of the ats conference at The Westin Harbour Castle, One Harbour Square, Toronto, Ontar...

Concomitant Use of Nebulized Formoterol Fumarate and Tiotropium Provides Significant Improvement in Dyspnea, COPD Symptoms and Rescue Medication Use over Tiotropium Alone

...lation Solution presented at International ats Conference -- NAPA, Calif., May 20 /PRNewswire/ ... dosing via nebulization." For those attending ats 2008, the presentation is available as follows: ...mptoms in COPD Patients The research presented at ats 2008 was supported through grants provided by Dey,...

Forest and Almirall Announce Positive Results of Clinical Studies for Aclidinium Bromide, a Novel, Long-Acting Anticholinergic for the Treatment for COPD

... had a potent and long-lasting effect on preventing bronchoconstriction in both the human bronchi and several animal models assessed. Abstracts from ats 2008 will be available upon request. About Aclidinium Bromide Aclidinium bromide is a novel, inhaled anticholinergic bronchodilator that is curren...

More>>

ATS in Biological Technology

ATS Medical Provides Update on US Commercialization of Its ATS 3f Aortic Bioprosthesis

MINNEAPOLIS, Dec. 8 /PRNewswire-FirstCall/ -- ATS Medical, Inc. (Nasdaq: ATSI ), manufacturer and marketer of state-of-the-art cardiac surgery products and services, today announced it has received FDA clearance for the marketing of the ATS 3f(R) Aortic Bioprosthesis that includes a new sewing t...

ATS Medical Confirms Excellent Durability of the ATS Open Pivot Mechanical Heart Valve

MINNEAPOLIS, July 9 /PRNewswire-FirstCall/ -- ATS Medical, Inc. (Nasdaq: ATSI ), manufacturer and marketer of state-of-the-art cardiac surgery products and services, today announced it has obtained new in vivo data to support the outstanding wear characteristics of the ATS Open Pivot(R) Mecha...

ATS Medical Announces Canadian Regulatory Approval of the ATS Open Pivot AP360 Mechanical Heart Valve

MINNEAPOLIS, June 23 /PRNewswire-FirstCall/ -- ATS Medical, Inc. (Nasdaq: ATSI ), manufacturer and marketer of state-of-the-art cardiac surgery products and services, today announced Health Canada -- Medical Device Bureau, Therapeutic Products Programme has approved use of the ATS Open Pivot(...

ATS Medical Announces First North American Commercial Implant of the ATS 3f Aortic Bioprosthesis

Follows Canadian regulatory approval of the ATS 3f Valve MINNEAPOLIS, April 10 /PRNewswire-FirstCall/ -- ATS Medical, Inc. (Nasdaq: ATSI ), manufacturer and marketer of state-of-the-art cardiac surgery products and services, today announced the first North American commercial implant ...

Results From Phase 3 CAPACITY Program of Pirfenidone in IPF and Study of Predictors of Mortality in IPF to be Presented at ATS

- Phase 3 CAPACITY results poster presentation Sunday, May 17, 8:15 a.m. PDT - - Phase 3 CAPACITY results oral presentation, Tuesday, May 19, 3:35 p.m. PDT - - Conference call and webcast Tuesday, May 19, 6 p.m. PDT - BRISBANE, Calif., May 14 /PRNewswire-FirstCall/ -- InterMun...

BioNeutral's Ygiene(TM) Hospital Grade Achieves a 100% Total Kill (Pass) Against the Life Threatening Clostridium Difficile (C.diff) Spores in Independent EPA Required Protocol Testing.

...based Life Science Company announced today that at ats Labs using the required EPA protocol testing, BioN...nc., Dr. Andy Kielbania stated, "These independent ats Labs test results completely validate our internal...angerous and resilient C.diff microorganism. These ats lab results stand firmly on their own accord and w...

BioNeutral's Ygiene(TM) Hospital Grade Achieves World Class Independent Test Results in Killing Life Threatening Spores/Organisms

...based Life Science company announced today that at ats Labs using the EPA required AOAC Sporicidal Test, ...ed: "These independent lab validation results from ats show that we have developed what we believe is the...ls well within those guidelines." About ats Labs: ...

BioNeutral's Ygiene(TM) Hospital Grade Antimicrobial Demonstrates a 99.9997% Kill Rate Against Clostridium Difficile Spores (C.diff) in Independent Lab Pre-testing Phase

...based Life Science company announced today that at ats Labs, using a Quantitative Disk Carrier test start...highly recognized independent laboratories such as ats Labs of Eagan, MN. In developing superior Ygiene(T...mand on the antimicrobial formulation. About ats Labs :...

Pulmonary Hypertension Association Names Dr. Nicholas Hill Recipient of 2009 Award of Excellence in Pulmonary Arterial Hypertension (PAH) Care

...ypertension and non-invasive ventilation. Dr. Hill currently serves as ats secretary-treasurer and will serve as ats president from 2011 to 2012. Dr. Hill is a member of the Strategic Planning...

ATS Medical Announces Participation in the Annual Meeting of the American Association for Thoracic Surgeons

... MINNEAPOLIS, May 7 /PRNewswire-FirstCall/ -- ats Medical, Inc. (Nasdaq: ATSI ), manufacturer and ... Highlighting ATS's broad product offering is the ats 3f(R) Aortic Bioprosthesis designed to replace the patient's diseased valve. The ats 3f Aortic Bioprosthesis is a revolutionary next ge...

More>>

Other Tags
(Date:7/22/2014)... A Florida woman has filed a ... the death of her husband was the result of ... Liebhard LLP reports. According to her complaint, which was ... Southern District of Florida on June 23rd, the decedent ... subdural hemorrhage the following June. Despite emergency treatment, his ...
(Date:7/22/2014)... 22, 2014) The American Society of Hematology ... University of California Los Angeles with the 2014 ... iron homeostasis, including the discovery of the iron-regulatory hormone ... This award, named after the Nobel Prize Laureate and ... research achievements in hematology that have represented a paradigm ...
(Date:7/22/2014)... you,re a member of the Clean Plate Club you ... you,re not alone! A new Cornell University study shows ... she puts on his or her plate. "If ... stomach," says Brian Wansink Ph.D., author of the forthcoming book, ... Cornell Food and Brand Lab. , Wansink and co-author Katherine ...
(Date:7/22/2014)... 2014) -- The American Society of Hematology (ASH) will ... Coulter Award for Lifetime Achievement in Hematology, to Kanti ... Jewish (LIJ) School of Medicine for his 50-year career ... and mentoring, and exceptional patient care. , The ... is bestowed on an individual who has been a ...
(Date:7/22/2014)... July 22, 2014 SIMpalm, ... updated payment app for Forte Payment System. Forte Mobile ... ACH payments on iPhone, iPod and iPad. The ... been recently updated by SIMpalm. This update was for ... currently supported on iOS 4.3 and is available to ...
Breaking Medicine News(10 mins):Health News:Xarelto Lawsuit Filed by Florida Woman Alleges Uncontrollable Bleeding Led to Husband’s Death, Bernstein Liebhard LLP Reports 2Health News:Xarelto Lawsuit Filed by Florida Woman Alleges Uncontrollable Bleeding Led to Husband’s Death, Bernstein Liebhard LLP Reports 3Health News:Tomas Ganz, M.D., Ph.D., to present 2014 ASH E. Donnall Thomas Lecture 2Health News:Tomas Ganz, M.D., Ph.D., to present 2014 ASH E. Donnall Thomas Lecture 3Health News:ASH honors Kanti R. Rai, M.D., with Coulter Award for Lifetime Achievement 2Health News:ASH honors Kanti R. Rai, M.D., with Coulter Award for Lifetime Achievement 3Health News:ASH honors Kanti R. Rai, M.D., with Coulter Award for Lifetime Achievement 4Health News:SIMpalm Launched Updated Forte Mobile Payment App on iPhone and iPad for Its Client 2Health News:SIMpalm Launched Updated Forte Mobile Payment App on iPhone and iPad for Its Client 3
(Date:7/22/2014)... feature natural habitats and trees and not just asphalt ... to a University of Colorado Boulder study. , Working ... provide stress-reducing benefits for youth, according to a paper ... The study is one of the first of its ... to green settings and stress. , "Many schools already ...
(Date:7/22/2014)... Conn. , July 22, 2014 ... the growing m-commerce market, announces its next generation smart ... 30-minute consumer oriented television show that airs on ... NewsWatch regularly features top technology ... July 31st on the History Channel (6:00-6:30am ET/PT) ...
(Date:7/21/2014)... researchers have detected genetic fragments of Middle East Respiratory ... holding a camel infected with the virus. The work, ... open-access journal of the American Society for Microbiology, indicates ... disease can be transmitted through the air. , MERS, ... has been identified in 699 people as of June ...
Breaking Biology News(10 mins):Natural-terrain schoolyards reduce children's stress, says Colorado University-Boulder study 2Natural-terrain schoolyards reduce children's stress, says Colorado University-Boulder study 3NXT-ID's Next Generation Wocket Smart Wallet to be Featured on NewsWatch, Airing on History Channel, FYI Network and ION Network 2NXT-ID's Next Generation Wocket Smart Wallet to be Featured on NewsWatch, Airing on History Channel, FYI Network and ION Network 3Middle East Respiratory Syndrome coronavirus detected in the air of a Saudi Arabian camel barn 2
Other Contents